Literature DB >> 23530947

Probing with mitomycin-C in adults with nasolacrimal duct obstruction.

Mohamed Amin Ghobadifar, Nader Degani, Iman Dezhkam, Nazanin Rezaei.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23530947      PMCID： PMC3708622          DOI： 10.1089/jop.2013.0006

Source DB:  PubMed          Journal:  J Ocul Pharmacol Ther        ISSN： 1080-7683            Impact factor:   2.671


× No keyword cloud information.
  4 in total

1.  CONSORT 2010 Statement: Updated guidelines for reporting parallel group randomised trials.

Authors:  Kenneth F Schulz; Douglas G Altman; David Moher
Journal:  J Clin Epidemiol       Date:  2010-03-25       Impact factor: 6.437

2.  Improving the quality of reporting of randomized controlled trials. The CONSORT statement.

Authors:  C Begg; M Cho; S Eastwood; R Horton; D Moher; I Olkin; R Pitkin; D Rennie; K F Schulz; D Simel; D F Stroup
Journal:  JAMA       Date:  1996-08-28       Impact factor: 56.272

3.  Efficacy of probing with mitomycin-C in adults with primary acquired nasolacrimal duct obstruction.

Authors:  Manish Kumar Sinha; Mandeep S Bajaj; Neelam Pushker; Supriyo Ghose; Mahesh Chandra
Journal:  J Ocul Pharmacol Ther       Date:  2012-11-12       Impact factor: 2.671

4.  Efficacy of probing the nasolacrimal duct with adjunctive Mitomycin-C for epiphora in adults.

Authors:  Chieh-Chih Tsai; Hui-Chuan Kau; Shu-Ching Kao; Wen-Ming Hsu; Jorn-Hon Liu
Journal:  Ophthalmology       Date:  2002-01       Impact factor: 12.079
  4 in total
  1 in total

1.  Nine-Month Follow-up Results of Treatment for Nasolacrimal Duct Obstruction by Probing with Adjunctive Mitomycin C in Adults: A Prospective Randomized Placebo-Controlled Trial.

Authors:  Nader Dehghani; Mohamad Reza Fouladivanda; Mohamed Amin Ghobadifar; Gelayol Safshekan-Esfahani; Armin Akbarzadeh
Journal:  Chonnam Med J       Date:  2015-04-14
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.